Status | Study |
Recruiting |
Study Name: Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors Condition: Germ Cell Tumor Date: 2017-02-28 Interventions: Drug: Durvalumab anti-PD-L1 mo |
Recruiting |
Study Name: Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors Condition: Germ Cell Tumor Date: 2016-12-01 Interventions: Drug: Brentuximab Vedotin Dose |
Recruiting |
Study Name: Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor Condition: Intracranial Non-germinomatous Germ Cell Tumor Date: 2016-05-24 Interventions: Drug: Carboplatin Drug: Etoposide |
Recruiting |
Study Name: Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor Condition: Testicular Germ Cell Tumor Date: 2016-02-05 Interventions: Other: EORTC QLQ-CIPN20 EORTC QLQ-CIPN20 is a 20-item chemotherapy-induced peripheral neuropathy-specifi |
Recruiting |
Study Name: Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours Condition: Germ Cell Tumor Date: 2015-09-07 Interventions: Drug: Bleomycin (active name: Bleomycin Sulfate) |
Recruiting |
Study Name: A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors Condition: Non-seminomatous Germ-cell Tumors Date: 2014-04-10 Interventions: Drug: Cabazitaxel On Day 1 of each cycle, patients will receive cabazitaxel at a dose of 25 mg/m², |
Recruiting |
Study Name: A Case-control Study to Assess the Association Between Environmental, Domestic and Occupational Exposures and the Risk of Testicular Germ Cell Tumor Condition: Testicular Germ Cell Tumor Date: 2014-04-08 Interventions: Other: Phone interview and blood test Subjects will be interviewed about environmental, domestic and occ |
Recruiting |
Study Name: A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent Condition: Extra Cranial Non Seminomateous Malignant Germ Cell Tumour Date: 2014-03-27 Interventions: Drug: Velbe-Bleomycin-Cisplatin |
Recruiting |
Study Name: Germ Cell Tumor and Testicular Tumor DNA Registry Condition: Germ Cell Tumor Testicular Tumor Date: 2014-03-26 Interventions: Behavioral: Questionnaires Other: sample o |
Recruiting |
Study Name: Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors Condition: Germ Cell Tumor Date: 2013-10-11 Interventions: Drug: Bevacizumab Drug: ICE chemotherapy r |